Oral Genome has filed a notice of an exempt offering of securities to raise $5,107,595.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Oral Genome is raising up to $5,107,595.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…